Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation.

Jones GW, Stumhofer JS, Foster T, Twohig JP, Hertzog P, Topley N, Williams AS, Hunter CA, Jenkins BJ, Wang EC, Jones SA.

FASEB J. 2011 Jan;25(1):409-19. doi: 10.1096/fj.10-166843. Epub 2010 Sep 8.

2.

TL1A increased the differentiation of peripheral Th17 in rheumatoid arthritis.

Zhou M, Liu R, Su D, Feng X, Li X.

Cytokine. 2014 Sep;69(1):125-30. doi: 10.1016/j.cyto.2014.04.007. Epub 2014 May 13.

PMID:
24832108
3.

TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.

Meylan F, Richard AC, Siegel RM.

Immunol Rev. 2011 Nov;244(1):188-96. doi: 10.1111/j.1600-065X.2011.01068.x. Review.

4.

Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.

Siakavellas SI, Bamias G.

Inflamm Bowel Dis. 2015 Oct;21(10):2441-52. doi: 10.1097/MIB.0000000000000492. Review.

PMID:
26099067
5.

Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.

Bamias G, Mishina M, Nyce M, Ross WG, Kollias G, Rivera-Nieves J, Pizarro TT, Cominelli F.

Proc Natl Acad Sci U S A. 2006 May 30;103(22):8441-6. Epub 2006 May 12.

6.

The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.

Meylan F, Davidson TS, Kahle E, Kinder M, Acharya K, Jankovic D, Bundoc V, Hodges M, Shevach EM, Keane-Myers A, Wang EC, Siegel RM.

Immunity. 2008 Jul 18;29(1):79-89. doi: 10.1016/j.immuni.2008.04.021. Epub 2008 Jun 19.

7.

Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.

Ahn YO, Weeres MA, Neulen ML, Choi J, Kang SH, Heo DS, Bergerson R, Blazar BR, Miller JS, Verneris MR.

Eur J Immunol. 2015 Aug;45(8):2335-42. doi: 10.1002/eji.201445213. Epub 2015 Jun 22.

9.

Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1.

Brunsing RL, Prossnitz ER.

Immunology. 2011 Sep;134(1):93-106. doi: 10.1111/j.1365-2567.2011.03471.x. Epub 2011 Jul 2.

10.

The TNF-family cytokine TL1A inhibits proliferation of human activated B cells.

Cavallini C, Lovato O, Bertolaso A, Pacelli L, Zoratti E, Zanolin E, Krampera M, Zamò A, Tecchio C, Cassatella MA, Pizzolo G, Scupoli MT.

PLoS One. 2013;8(4):e60136. doi: 10.1371/journal.pone.0060136. Epub 2013 Apr 2.

11.

The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.

Richard AC, Tan C, Hawley ET, Gomez-Rodriguez J, Goswami R, Yang XP, Cruz AC, Penumetcha P, Hayes ET, Pelletier M, Gabay O, Walsh M, Ferdinand JR, Keane-Myers A, Choi Y, O'Shea JJ, Al-Shamkhani A, Kaplan MH, Gery I, Siegel RM, Meylan F.

J Immunol. 2015 Apr 15;194(8):3567-82. doi: 10.4049/jimmunol.1401220. Epub 2015 Mar 18. Erratum in: J Immunol. 2015 Dec 15;195(12):5839-40.

12.

TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.

Kamada N, Hisamatsu T, Honda H, Kobayashi T, Chinen H, Takayama T, Kitazume MT, Okamoto S, Koganei K, Sugita A, Kanai T, Hibi T.

Inflamm Bowel Dis. 2010 Apr;16(4):568-75. doi: 10.1002/ibd.21124.

PMID:
19834969
13.

TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.

Ślebioda TJ, Bojarska-Junak A, Stanisławowski M, Cyman M, Wierzbicki PM, Roliński J, Celiński K, Kmieć Z.

Scand J Immunol. 2015 Oct;82(4):352-60. doi: 10.1111/sji.12324.

14.

TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.

Takedatsu H, Michelsen KS, Wei B, Landers CJ, Thomas LS, Dhall D, Braun J, Targan SR.

Gastroenterology. 2008 Aug;135(2):552-67. doi: 10.1053/j.gastro.2008.04.037. Epub 2008 May 7.

15.

Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.

Papadakis KA, Zhu D, Prehn JL, Landers C, Avanesyan A, Lafkas G, Targan SR.

J Immunol. 2005 Apr 15;174(8):4985-90.

16.

TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease.

Pappu BP, Borodovsky A, Zheng TS, Yang X, Wu P, Dong X, Weng S, Browning B, Scott ML, Ma L, Su L, Tian Q, Schneider P, Flavell RA, Dong C, Burkly LC.

J Exp Med. 2008 May 12;205(5):1049-62. doi: 10.1084/jem.20071364. Epub 2008 Apr 14.

17.

1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells.

Ikeda U, Wakita D, Ohkuri T, Chamoto K, Kitamura H, Iwakura Y, Nishimura T.

Immunol Lett. 2010 Nov 30;134(1):7-16. doi: 10.1016/j.imlet.2010.07.002. Epub 2010 Jul 23.

PMID:
20655952
18.

The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.

Twohig JP, Marsden M, Cuff SM, Ferdinand JR, Gallimore AM, Perks WV, Al-Shamkhani A, Humphreys IR, Wang EC.

FASEB J. 2012 Aug;26(8):3575-86. doi: 10.1096/fj.11-200618. Epub 2012 May 16.

19.

Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.

Cavallini C, Lovato O, Bertolaso A, Zoratti E, Malpeli G, Mimiola E, Tinelli M, Aprili F, Tecchio C, Perbellini O, Scarpa A, Zamò A, Cassatella MA, Pizzolo G, Scupoli MT.

Oncotarget. 2015 Oct 13;6(31):32061-74. doi: 10.18632/oncotarget.5201.

20.

Role of TL1A in the pathogenesis of rheumatoid arthritis.

Zhang J, Wang X, Fahmi H, Wojcik S, Fikes J, Yu Y, Wu J, Luo H.

J Immunol. 2009 Oct 15;183(8):5350-7. doi: 10.4049/jimmunol.0802645. Epub 2009 Sep 28.

Supplemental Content

Support Center